Abstract

Background: The International Academy of Cytology (IAC) has established standardizedapproach for reporting breast FNAC by categorizing lesions in a five-tier system from C1 to C5. Materials and Methods: From May 2020 to April 2021, a descriptive cross-sectional study was conducted in the cytology section of the Department of Pathology, SMS Medical College, Jaipur. Results: The current study involved 335 cases of breast FNAC, with a maximum of 333 (99.40%) females and 2 (0.60%) males. Maximum cases were in the age range of 21-40 years. There were 79 (23.60%) cases in C1 (Insufficient) category, C2 (Benign) had 177 (52.80%) cases, C3 (Atypical) had 9 (2.70%) cases, C4 (Suspicious) had 16 (4.80%) cases, and C5 (Malignant) had 54 (16.10%) cases respectively. Fibroadenoma was the most prevalent benign lesion in our analysis, accounting for 45 of the 177 benign cases, whereas ductal carcinoma was the most common malignant lesion.In a total of 92 cases where histology was examined, 86 cases were found to be compatible with the cytological diagnosis. In a triple assessment, 103 (78.03%) of the 132 cases were concordant in the benign group, only 1 (12.50%) case showed concordance in the atypia category, and 21 (39.62%) of the 53 cases showed concordance in the suspicious or malignant category. The Risk Of Malignancy (ROM) was calculated as follows: inadequate 0%, benign 0%, atypia 0%, suspicious for malignancy 71.43%, and malignant 97.56% for each group. Conclusion: This system is a valuable tool for breast cancer patient diagnosis and care. It also simplifies clinical audits and aids in improved coordination between pathologists, hospitals, and institutes.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.